Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
The article presents an analysis of the therapeutic effect of the drug diacerein (D), which has been used in osteoarthritis (OA) for more than 20 years and is included in the clinical guidelines of the Association of Rheumatologists of Russia (2021) and the European Society for Clinical and Economic...
Main Authors: | I. B. Belyaeva, V. I. Mazurov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-08-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1329 |
Similar Items
-
Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01) -
Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01) -
Diacerein: A New Disease Modulating Agent in Osteoarthritis
by: Medhi B, et al.
Published: (2007-10-01) -
NEW OPPORTUNITIES THERAPY IN PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AND METABOLIC SYNDROME
by: L. I. Alexeeva, et al.
Published: (2018-02-01) -
Comparison Of Diacerein-Ginger With Diacerein Alone In Treating Knee Osteoarthritis
by: Mehtab Munir, et al.
Published: (2019-12-01)